These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 18980046
21. Management of Acne Vulgaris: A Review. Eichenfield DZ, Sprague J, Eichenfield LF. JAMA; 2021 Nov 23; 326(20):2055-2067. PubMed ID: 34812859 [Abstract] [Full Text] [Related]
24. A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment. Maloney JM, Dietze P, Watson D, Niknian M, Lee-Rugh S, Sampson-Landers C, Korner P. J Drugs Dermatol; 2009 Sep 23; 8(9):837-44. PubMed ID: 19746676 [Abstract] [Full Text] [Related]
25. New developments in hormonal therapy for acne. Tan JK. Skin Therapy Lett; 2007 Sep 23; 12(7):1-3. PubMed ID: 17940710 [Abstract] [Full Text] [Related]
26. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism. Batukan C, Muderris II. Fertil Steril; 2006 Feb 23; 85(2):436-40. PubMed ID: 16595223 [Abstract] [Full Text] [Related]
27. Isotretinoin: new therapy for severe acne. Perry MD, McEvoy GK. Clin Pharm; 1983 Feb 23; 2(1):12-9. PubMed ID: 6192964 [Abstract] [Full Text] [Related]
28. YAZ in the treatment of premenstrual dysphoric disorder. Rapkin AJ. J Reprod Med; 2008 Sep 23; 53(9 Suppl):729-41. PubMed ID: 18980045 [Abstract] [Full Text] [Related]
29. Adolescent female acne: etiology and management. Olutunmbi Y, Paley K, English JC. J Pediatr Adolesc Gynecol; 2008 Aug 23; 21(4):171-6. PubMed ID: 18656070 [Abstract] [Full Text] [Related]
30. Common and alternate oral antibiotic therapies for acne vulgaris: a review. Amin K, Riddle CC, Aires DJ, Schweiger ES. J Drugs Dermatol; 2007 Sep 23; 6(9):873-80. PubMed ID: 17941358 [Abstract] [Full Text] [Related]
31. Acne vulgaris in childhood. Pathogenesis and management. Yonkosky DM, Pochi PE. Dermatol Clin; 1986 Jan 23; 4(1):127-36. PubMed ID: 2941198 [Abstract] [Full Text] [Related]
32. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations. Lello S, Primavera G, Colonna L, Vittori G, Guardianelli F, Sorge R, Raskovic D. Gynecol Endocrinol; 2008 Dec 23; 24(12):718-23. PubMed ID: 19172543 [Abstract] [Full Text] [Related]
33. The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris. Olson WH, Lippman JS, Robisch DM. Int J Fertil Womens Med; 1998 Dec 23; 43(6):286-90. PubMed ID: 9920537 [Abstract] [Full Text] [Related]
34. Acne treatment with a new estroprogestinic biphasic combination containing desogestrel. Falsetti L. Acta Eur Fertil; 1991 Dec 23; 22(5):283-6. PubMed ID: 1845752 [No Abstract] [Full Text] [Related]
38. Use of drospirenone/ethinyl estradiol (DRSP/EE) among women with acne reduces acne treatment-related resources. Joish VN, Boklage S, Lynen R, Schmidt A, Lin J. J Med Econ; 2011 Sep 23; 14(6):681-9. PubMed ID: 21892859 [Abstract] [Full Text] [Related]